当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Brief Note on Gestational Diabetes

Murk Zefo

Gestational diabetes mellitus (GDM) is a unique form of diabetes that manifests during pregnancy, affecting approximately 2-10% of pregnant women. This abstract provides a concise overview of GDM, its risk factors, impact on maternal and fetal health, diagnostic criteria, and management strategies. GDM arises due to hormonal changes during pregnancy, leading to insulin resistance. While many women with GDM can manage it through lifestyle modifications, such as diet and exercise, some may require medication or insulin therapy to control blood sugar levels. Timely diagnosis and effective management are essential to mitigate potential complications. GDM can have significant implications for maternal health, including an increased risk of preeclampsia, cesarean section, and type 2 diabetes later in life. Fetal health may also be compromised, with macrosomia and neonatal hypoglycemia being potential outcomes. Regular screening during pregnancy helps identify GDM, typically between the 24th and 28th weeks. Monitoring blood glucose levels, maintaining a balanced diet, and staying physically active are central to GDM management.